COVAX and the rise of the ‘super public private partnership’ for global health

References

• Andonova, L. B. (2017). Governance entrepreneurs: International organizations and the rise of global public-private partnerships. Cambridge University Press.
   Google Scholar
• Bartsch, S. (2011). A critical appraisal of global health partnerships. In S. Rushton & O. D. Williams (Eds.), Partnerships and foundations in global health governance (pp. 29–52). International Political Economy Series. Palgrave Macmillan.
   Google Scholar
• Birn, A.-E. (2005). Gates’s grandest challenge: Transcending technology as public health ideology. The Lancet, 366(9484), 514–519. https://doi.org/10.1016/S0140-6736(05)66479-3
   PubMed Web of Science ®Google Scholar
• Birn, A.-E. (2006). Marriage of convenience: Rockefeller International Health and Revolutionary Mexico (NED-New ed.). Boydell & Brewer. https://www.jstor.org/stable/10 .7722/j.ctt16314kz
   Google Scholar
• Bloomberg. (2021, August 10). BioNTech vaccine to give German economy extraordinary boost. Bloomberg.Com. https://www.bloomberg.com/news/articles/2021-08-10/biontech-vaccine-to-give-german-economy-extraordinary-boost
   Google Scholar
• Brown, T. M., Cueto, M., & Fee, E. (2006). The World Health Organization and the transition from ‘international’ to ‘global’ public health. American Journal of Public Health, 96(1), 62–72. https://doi.org/10.2105/AJPH.2004.050831
   PubMed Web of Science ®Google Scholar
• Bull, B., & McNeill, D. (2007). Development issues in global governance: Public-private partnerships and market multilateralism (1st ed.). Routledge.
   Google Scholar
• Bull, B., & McNeill, D. (2019). From market multilateralism to governance by goal setting: SDGs and the changing role of partnerships in a new global order. Business and Politics, 21(4), 464–486. https://doi.org/10.1017/bap.2019.9
   Web of Science ®Google Scholar
• Buse, K., & Bertram, K. (2021, June 13). G7 Leaders made few concrete, strong, or deep health-related commitments at Carbis Bay – BMJ Opinion blog. https://blogs.bmj.com/bmj/2021/06/13/g7-leaders-made-few-concrete-strong-or-deep-health-related-commitments-at-carbis-bay/
   Google Scholar
• Buse, K., & Harmer, A. (2004). Power to the partners?: The politics of public-private health partnerships. Development, 47(June), 49–56. https://doi.org/10.1057/palgrave.development.1100029
   Google Scholar
• Buse, K., & Harmer, A. M. (2007). Seven habits of highly effective global public–private health partnerships: Practice and potential. Social Science & Medicine, 64(2), 259–271. https://doi.org/10.1016/j.socscimed.2006.09.001
   PubMed Web of Science ®Google Scholar
• Covax. (2021, June 25). COVAX vaccine roll-out. https://www.gavi.org/covax-vaccine-roll-out
   Google Scholar
• Development Today. (2021a, April 14). UK buys 500,000 Pfizer vaccine doses from COVAX for domestic use. Development Today. https://development-today.com/archive/dt-2021/dt-3–2021/uk-buys-500-000-pfizer-vaccine-doses-from-covax-for-domestic-use
   Google Scholar
• Development Today. (2021b, November 11). Norway has donated almost 700,000 corona vaccine doses to poorer nations. Development Today. https://www.development-today.com/archive/dt-2021/dt-2–2021/norway-has-donated-almost-700-000-corona-vaccine-doses-to-poorer-nations
   Google Scholar
• Development Today. (2021c, July 13). Interview: Catherine Kyobutungi: Decolonise COVAX: An African critique. https://developmenttoday.com/archive/dt-2021/dt-5--2021/decolonising-covax-a-ugandan-epidemiologists-perspective
   Google Scholar
• Development Today. (2021d, March 11). Norway has donated almost 700,000 corona vaccine doses to poorer nations. Development Today. https://development-today.com/archive/dt-2021/dt-2--2021/norway-has-donated-almost-700-000-corona-vaccine-doses-to-poorer-nations
   Google Scholar
• Devex. (2021, March 11). Is COVAX part of the problem or the solution? Devex. https://www.devex.com/news/sponsored/is-covax-part-of-the-problem-or-the-solution-99334
   Google Scholar
• Duke Global Health Innovation Centre. (2021). COVID-19 | Launch and scale speedometer. https://launchandscalefaster.org/covid-19
   Google Scholar
• Eccleston-Turner, M., & Upton, H. (2021). International collaboration to ensure equitable access to vaccines for COVID-19: The ACT-accelerator and the COVAX facility. The Milbank Quarterly. Retrieved June 25. https://doi.org/10.1111/1468-0009.12503
   PubMed Web of Science ®Google Scholar
• EEAS. (2020, November 13). No to vaccine nationalism, yes to vaccine multilateralism. Text. EEAS – European External Action Service – European Commission. https://eeas.europa.eu/headquarters/headquarters-homepage/88701/no-vaccine-nationalism-yes-vaccine-multilateralism_en
   Google Scholar
• Fierce Pharma. (2021, July 30). Pfizer CEO says it’s ‘radical’ to suggest pharma should forgo profits on COVID-19 vaccine: Report | FiercePharma. https://www.fiercepharma.com/pharma/pfizer-ceo-says-it-s-radical-to-suggest-pharma-should-forgo-profits-covid-19-vaccine-report
   Google Scholar
• Fortune. (2020, August 24). Oxford’s COVID vaccine deal with AstraZeneca raises concerns about access and pricing. https://fortune.com/2020/08/24/oxford-astrazeneca-covid-vaccine-deal-pricing-profit-concerns/
   Google Scholar
• Gavi. (2020a). Operating model. https://www.gavi.org/our-alliance/operating-model
   Google Scholar
• Gavi. (2020b). COVAX welcomes appointment of civil society representatives. Retrieved October 30, from https://www.gavi.org/news/media-room/covax-welcomes-appointment-civil-society-representatives
   Google Scholar
• Gavi. (2020c, July 8). Up to 100 million COVID-19 vaccine doses to be made available for low- and middle-income countries as early as 2021. https://www.gavi.org/news/media-room/100-million-covid-19-vaccine-doses-available-low-and-middle-income-countries-2021
   Google Scholar
• Gavi. (2020d, December 18). COVAX_Principles-COVID-19-Vaccine-Doses-COVAX.Pdf. https://www.gavi.org/sites/default/files/covid/covax/COVAX_Principles-COVID-19-Vaccine-Doses-COVAX.pdf
   Google Scholar
• Gavi. (2020e, March 9). COVAX explained. https://www.gavi.org/vaccineswork/covax-explained
   Google Scholar
• Gavi. (2021a). 92 Low- and middle-income economies eligible to get access to COVID-19 vaccines through Gavi COVAX AMC. Retrieved August 25, from https://www.gavi.org/news/media-room/92-low-middle-income-economies-eligible-access-covid-19-vaccines-gavi-covax-amc
   Google Scholar
• Gavi. (2021b). COVAX_the-Vaccines-Pillar-of-the-Access-to-COVID-19-Tools-ACT-Accelerator.Pdf. https://www.gavi.org/sites/default/files/covid/covax/COVAX_the-Vaccines-Pillar-of-the-Access-to-COVID-19-Tools-ACT-Accelerator.pdf
   Google Scholar
• Gavi. (2021c, April 23). France makes important vaccine dose donation to COVAX. https://www.gavi.org/news/media-room/france-makes-important-vaccine-dose-donation-covax
   Google Scholar
• Gavi. (2021d, June 17). COVAX global supply forecast.
   Google Scholar
• Gavi. (2021e, September 1). COVAX supply forecast reveals where and when COVID-19 vaccines will be delivered. https://www.gavi.org/vaccineswork/covax-supply-forecast-reveals-where-when-covid-19-vaccines-will-be-delivered
   Google Scholar
• Gavi. (2021f, March 5). Gavi signs agreement with Moderna to secure doses on behalf of COVAX facility. https://www.gavi.org/news/media-room/gavi-signs-agreement-moderna-secure-doses-behalf-covax-facility
   Google Scholar
• Geneva Health Files, Priti. (2021, May 18). At risk: COVAX plans to vaccinate 20% of the people in LMICs. Geneva Health Files. https://genevahealthfiles.com/2021/05/18/at-risk-covax-plans-to-vaccinate-20-of-the-people-in-lmics/
   Google Scholar
• Holzscheiter, A., Thurid, B., & Laura, P. (2016). Emerging governance architectures in global health: Do metagovernance norms explain inter-organisational convergence? Politics and Governance, 4(3), 5–19. https://doi.org/10.17645/pag.v4i3.566
   Web of Science ®Google Scholar
• Medscape. (2020, August 26). They pledged to donate rights to their COVID vaccine. Medscape. http://www.medscape.com/viewarticle/936349
   Google Scholar
• MSF. (2020, July 20). Open letter to Gavi Board Members: Inclusion of civil society in COVAX facility and COVAX AMC governance is essential. Médecins Sans Frontières Access Campaign. https://msfaccess.org/open-letter-gavi-board-members-inclusion-civil-society-covax-facility-and-covax-amc-governance
   Google Scholar
• One.org. (2021, February 17). Vaccine Access Test. ONE. https://www.one.org/international/issues/vaccine-access-test/
   Google Scholar
• Pfizer. (2021, February 2). Pfizer full year 2020 reports. https://www.sec.gov/Archives/edgar/data/78003/000007800321000003/pfe-12312020xex99.htm
   Google Scholar
• Project Syndicate. (2021, May 6). Will corporate greed prolong the pandemic? | by Joseph E. Stiglitz & Lori Wallach. Project Syndicate. https://www.project-syndicate.org/onpoint/big-pharma-blocking-wto-waiver-to-produce-more-covid-vaccines-by-joseph-e-stiglitz-and-lori-wallach-2021-05
   Google Scholar
• Puyvallée, A. d. B., & Storeng, K. T. (2017, June). Protecting the vulnerable is protecting ourselves: Norway and the coalition for epidemic preparedness innovation. Tidsskrift for Den Norske Legeforening. https://doi.org/10.4045/tidsskr.17.0208
   Google Scholar
• Reuters. (2020, December 14). EU weighs donating 5% of its COVID-19 vaccines to poor nations-document. Reuters. https://www.reuters.com/business/healthcare-pharmaceuticals/eu-weighs-donating-5-its-covid-19-vaccines-poor-nations-document-2020-12-14/
   Google Scholar
• Reuters. (2021a, January 22). Exclusive: Pfizer-BioNTech agree to supply WHO co-led COVID-19 vaccine scheme – Sources. Reuters. Sec. Healthcare & Pharma. https://www.reuters.com/article/us-health-coronavirus-covax-pfizer-exclu-idUSKBN29Q2R9
   Google Scholar
• Reuters. (2021b, February 26). Vaccine hoarding threatens global supply via COVAX: WHO. Reuters. Sec. Healthcare & Pharmaceuticals. https://www.reuters.com/article/us-health-coronavirus-who-covax-idUSKBN2AQ2O5
   Google Scholar
• Reuters (2021c, June 16). Analysis: G7′s billion vaccine plan counts some past pledges, limiting impact. https://www.reuters.com/business/healthcare-pharmaceuticals/g7s-billion-vaccine-plan-counts-some-past-pledges-limiting-impact-2021-06-13/?taid=60c5e8bebd67900001a8dbf8&utm_campaign=trueanthem&utm_medium=trueanthem&utm_source=twitter
   Google Scholar
• Rushton, S., & Williams, O. (2011). Partnerships and foundations in global health governance. Springer.
   Google Scholar
• Schaik, L. v., Jørgensen, K. E., & van de Pas, R. (2020). Loyal at once? The EU’s global health awakening in the Covid-19 pandemic. Journal of European Integration, 42(8), 1145–1160. https://doi.org/10.1080/07036337.2020.1853118
   Web of Science ®Google Scholar
• Shiffman, J. (2017). Four challenges that global health networks face. International Journal of Health Policy and Management, 6(4), 183–189. https://doi.org/10.15171/ijhpm.2017.14
   PubMed Web of Science ®Google Scholar
• Stein, F. (2021). Risky business: COVAX and the financialization of global vaccine equity. Globalization and Health, 17(1), 1–11. https://doi.org/10.1186/s12992-021-00763-8
   Google Scholar
• Storeng, K. T. (2014). The GAVI alliance and the ‘Gates Approach’ to health system strengthening. Global Public Health, 9(8), 865–879. https://doi.org/10.1080/17441692.2014.940362
   PubMed Web of Science ®Google Scholar
• Storeng, K. T., & de Bengy Puyvallée, A. (2018). Civil society participation in global public private partnerships for health. Health Policy and Planning, 33(August). https://doi.org/10.1093/heapol/czy070
   PubMedGoogle Scholar
• Storeng, K. T., & de Bengy Puyvallée, A. (2020, December 3). Why does Pfizer deny the public investment in Its Covid-19 vaccine? International Health Policies. https://www.internationalhealthpolicies.org/featured-article/why-does-pfizer-deny-the-public-investment-in-its-covid-19-vaccine/
   Google Scholar
• Storeng, K. T., de Bengy Puyvallée, A., Stein, F., & McNeill, D. (2021). What Norway should ask of the pharmaceutical industry in the Covid-19 pandemic [Policy Brief]. https://www.sum.uio.no/english/research/projects/norways-public-private-cooperation-for-pandemic-p/policy-briefs/policy-brief-panprep-sum-uio-03-2021-what-norway-should-ask-of-the-pharma.pdf
   Google Scholar
• The Bureau of Investigative Journalism. (2021, February 23). ‘Held to Ransom’: Pfizer demands governments gamble with state assets to secure vaccine deal. The Bureau of Investigative Journalism. https://www.thebureauinvestigates.com/stories/2021-02-23/held-to-ransom-pfizer-demands-governments-gamble-with-state-assets-to-secure-vaccine-deal
   Google Scholar
• The Guardian. (2020, June 4). World leaders must fund a Covid-19 vaccine plan before it’s too late for millions | Gro Harlem Brundtland and Elizabeth Cousens. The Guardian. http://www.theguardian.com/commentisfree/2020/jun/04/world-leaders-fund-covid-19-vaccine-global-vaccine-summit
   Google Scholar
• The Guardian. (2021a, January 22). South Africa paying more than double EU price for Oxford vaccine. The Guardian. http://www.theguardian.com/world/2021/jan/22/south-africa-paying-more-than-double-eu-price-for-oxford-astrazeneca-vaccine
   Google Scholar
• The Guardian. (2021b, June 24). Rich countries ‘deliberately’ keeping Covid Vaccines from Africa, Says Envoy. The Guardian. http://www.theguardian.com/global-development/2021/jun/24/rich-countries-deliberately-keeping-covid-vaccines-from-africa-says-envoy
   Google Scholar
• The Loop. (2021, May 25). Vaccine prices may become a political powder Keg – Felix Stein. https://theloop.ecpr.eu/vaccine-prices-may-become-a-political-powder-keg/
   Google Scholar
• The New Republic. (2021, April 12). How Bill Gates impeded global access to Covid vaccines. The New Republic. https://newrepublic.com/article/162000/bill-gates-impeded-global-access-covid-vaccines
   Google Scholar
• The New York Times. (2021, March 11). The U.S. is sitting on tens of millions of vaccine doses the world needs. The New York Times. Sec. U.S. https://www.nytimes.com/2021/03/11/us/politics/coronavirus-astrazeneca-united-states.html
   Google Scholar
• The People’s Vaccine. (2021). Join the #PeoplesVaccine global day of action. Peoples Vaccine. https://peoplesvaccine.org/take-action/
   Google Scholar
• The Washington Post. (2021, February 13). Moderna pledged to make its vaccine accessible to poor countries, but most vaccines have gone to wealthier nations. – Emily Rauhala. Washington Post. https://www.washingtonpost.com/gdpr-consent/
   Google Scholar
• The White House. (2021, June 10). FACT SHEET: President Biden announces historic vaccine donation: Half a Billion Pfizer vaccines to the world’s lowest-income nations. The White House. https://www.whitehouse.gov/briefing-room/statements-releases/2021/06/10/fact-sheet-president-biden-announces-historic-vaccine-donation-half-a-billion-pfizer-vaccines-to-the-worlds-lowest-income-nations/
   Google Scholar
• Toronto Sun. (2021). LILLEY: Trudeau makes Canada ‘vaccine pirate,’ stealing from poor nations. Torontosun. Retrieved February 28, from https://torontosun.com/opinion/columnists/lilley-trudeau-makes-canada-vaccine-pirate-stealing-from-poor-nations
   Google Scholar
• UN. (2015). Transforming our world: The 2030 agenda for sustainable development | Department of Economic and Social Affairs. Retrieved October 21, from https://sdgs.un.org/2030agenda
   Google Scholar
• UN. (2021, May 21). COVID-19: UN Chief calls for G20 Vaccine Task Force, in ‘war’ against the virus. UN News. https://news.un.org/en/story/2021/05/1092442
   Google Scholar
• Usher, A. D. (2021). A beautiful idea: How COVAX has fallen short. The Lancet, 397(10292), 2322–2325. https://doi.org/10.1016/S0140-6736(21)01367-2
   PubMed Web of Science ®Google Scholar
• Vanity Fair, C. (2021, June 4). ‘We are hoarding’: Why the U.S. still can’t donate COVID-19 vaccines to countries in need. Vanity Fair. https://www.vanityfair.com/news/2021/04/why-the-us-still-cant-donate-covid-19-vaccines-to-countries-in-need
   Google Scholar
• WHO. (2009, June). Maximizing positive synergies: Interactions between global health initiatives and health systems: Evidence from countries, 250.
   Google Scholar
• WHO. (2021). The ACT Accelerator Interactive Funding Tracker. Retrieved June 25, from https://www.who.int/initiatives/act-accelerator/funding-tracker
   Google Scholar
• WHO. (2021a). COVAX. https://www.who.int/initiatives/act-accelerator/covax
   Google Scholar
• WHO. (2021b, June 26). Access to COVID-19 Tools Funding Commitment Tracker. https://www.who.int/publications/m/item/access-to-covid-19-tools-tracker
   Google Scholar
• World Economic Forum. (2021, September 2). 4 Principles for urgent pharma action to combat COVID-19. Access to Medicine Foundation. https://accesstomedicinefoundation.org/in-the-media/4-principles-for-urgent-pharma-action-to-combat-covid-19
   Google Scholar
• Yamey, G., Schäferhoff, M., Pate, M., Chawla, M., Ranson, K., Hatchett, R., & Wilder, R. (2020). Funding the development and manufacturing of COVID-19 vaccines (SSRN Scholarly Paper ID 3575660). Social Science Research Network. https://doi.org/10.2139/ssrn.3575660
   Google Scholar